Eyebright Medical Technology (Beijing) Past Earnings Performance
Past criteria checks 2/6
Eyebright Medical Technology (Beijing) has been growing earnings at an average annual rate of 34.3%, while the Medical Equipment industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 39.1% per year. Eyebright Medical Technology (Beijing)'s return on equity is 13.2%, and it has net margins of 28.4%.
Key information
34.3%
Earnings growth rate
30.4%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 39.1% |
| Return on equity | 13.2% |
| Net Margin | 28.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Revenue & Expenses Breakdown
How Eyebright Medical Technology (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,230 | 349 | 371 | 98 |
| 31 Mar 24 | 1,072 | 328 | 345 | 93 |
| 31 Dec 23 | 951 | 304 | 309 | 92 |
| 30 Sep 23 | 806 | 287 | 276 | 85 |
| 30 Jun 23 | 713 | 272 | 239 | 79 |
| 31 Mar 23 | 638 | 252 | 205 | 72 |
| 31 Dec 22 | 579 | 233 | 187 | 64 |
| 30 Sep 22 | 549 | 229 | 168 | 59 |
| 30 Jun 22 | 500 | 203 | 160 | 56 |
| 31 Mar 22 | 480 | 194 | 157 | 54 |
| 31 Dec 21 | 433 | 171 | 148 | 52 |
| 30 Sep 21 | 416 | 168 | 137 | 48 |
| 30 Jun 21 | 376 | 150 | 122 | 40 |
| 31 Mar 21 | 331 | 129 | 107 | 36 |
| 31 Dec 20 | 273 | 97 | 98 | 30 |
| 30 Sep 20 | 237 | 86 | 86 | 26 |
| 30 Jun 20 | 204 | 68 | 82 | 24 |
| 31 Mar 20 | 178 | 53 | 84 | 23 |
| 31 Dec 19 | 195 | 67 | 82 | 22 |
| 31 Dec 18 | 127 | 20 | 71 | 14 |
| 31 Dec 17 | 75 | -4 | 55 | 7 |
Quality Earnings: 688050 has a high level of non-cash earnings.
Growing Profit Margin: 688050's current net profit margins (28.4%) are lower than last year (38.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688050's earnings have grown significantly by 34.3% per year over the past 5 years.
Accelerating Growth: 688050's earnings growth over the past year (28.1%) is below its 5-year average (34.3% per year).
Earnings vs Industry: 688050 earnings growth over the past year (28.1%) exceeded the Medical Equipment industry 1.6%.
Return on Equity
High ROE: 688050's Return on Equity (13.2%) is considered low.